ArticleCancer medicine2026

Effects of Vemurafenib ± Cobimetinib on Intratumoral and Host Immunity in Patients With BRAFV600 Mutant Melanoma: Implications for Combination With Immunotherapy.

Suthee Rapisuwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.